| Literature DB >> 33382973 |
Michael Heming1, Xiaolin Li1, Saskia Räuber1, Anne K Mausberg2, Anna-Lena Börsch1, Maike Hartlehnert1, Arpita Singhal3, I-Na Lu1, Michael Fleischer2, Fabian Szepanowski2, Oliver Witzke4, Thorsten Brenner5, Ulf Dittmer6, Nir Yosef7, Christoph Kleinschnitz2, Heinz Wiendl1, Mark Stettner8, Gerd Meyer Zu Hörste9.
Abstract
Patients suffering from Coronavirus disease 2019 (COVID-19) can develop neurological sequelae, such as headache and neuroinflammatory or cerebrovascular disease. These conditions-termed here as Neuro-COVID-are more frequent in patients with severe COVID-19. To understand the etiology of these neurological sequelae, we utilized single-cell sequencing and examined the immune cell profiles from the cerebrospinal fluid (CSF) of Neuro-COVID patients compared with patients with non-inflammatory and autoimmune neurological diseases or with viral encephalitis. The CSF of Neuro-COVID patients exhibited an expansion of dedifferentiated monocytes and of exhausted CD4+ T cells. Neuro-COVID CSF leukocytes featured an enriched interferon signature; however, this was less pronounced than in viral encephalitis. Repertoire analysis revealed broad clonal T cell expansion and curtailed interferon response in severe compared with mild Neuro-COVID patients. Collectively, our findings document the CSF immune compartment in Neuro-COVID patients and suggest compromised antiviral responses in this setting.Entities:
Keywords: COVID-19; Neuro-COVID; SARS-CoV-2; T cell exhaustion; cerebrospinal fluid; interferon-stimulated genes; neurological manifestation; single-cell RNA sequencing; transcriptomics
Year: 2020 PMID: 33382973 DOI: 10.1016/j.immuni.2020.12.011
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745